Thrivent Financial for Lutherans’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,946
Closed -$214K 2467
2023
Q1
$214K Hold
2,946
﹤0.01% 2370
2022
Q4
$241K Hold
2,946
﹤0.01% 2304
2022
Q3
$279K Hold
2,946
﹤0.01% 2248
2022
Q2
$573K Buy
+2,946
New +$573K ﹤0.01% 2026
2021
Q2
Sell
-1,785
Closed -$641K 2456
2021
Q1
$641K Sell
1,785
-1,850
-51% -$664K ﹤0.01% 2129
2020
Q4
$1.78M Buy
3,635
+1,514
+71% +$743K ﹤0.01% 1389
2020
Q3
$687K Sell
2,121
-17
-0.8% -$5.51K ﹤0.01% 1806
2020
Q2
$779K Hold
2,138
﹤0.01% 1666
2020
Q1
$455K Buy
+2,138
New +$455K ﹤0.01% 1768